Septic Arthritis Market Multiply Relentlessly; Asserts MRFR Unleashing Industry Forecast

Pune, India, January, 2018/MRFR Press Release/- Market Research Future published a Half Cooked research report on “Septic Arthritis Market Research Report - Forecast till 2023”  – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Lupin Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Swtizerland), AbbVie Inc. (U.S.), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Johnson & Johnson Inc. (U.S.), and Pfizer (U.S.) are some of the leading players at the cutting edge of the competition in the market of septic arthritis, globally.

Septic arthritis, also refer as infectious arthritis is a painful infection that normally occur in the joint of the body such as the knee or hip. Staphylococcus and streptococcus are the most common bacteria that cause acute septic arthritis in both adults and children. These bacteria usually spread from one area of the body to another through the blood stream. Septic arthritis can also occur from open wounds and opening form of surgical procedure. Moreover, weak immune system and people who suffering with diseases such as, cancer, diabetes, and intravenous drug abuse have a more chance to develop septic arthritis. According to National Cancer Institute, in 2016, the U.S. diagnosed around 1,685,210 new cases of cancer, and in 2014, around 15,780 children and adolescents ages 0 to 19 were diagnosed with cancer and 1,960 died of the disease. Additionally, according to the report published by the Centers for Disease Control and Prevention (CDC) in 2017, around 78 million adults in the U.S. are estimated to be diagnosed with arthritis. Thus, the increase prevalence of arthritis, diabetes, and cancer patients are raising the chances of occurring Septic arthritis throughout the globe.

Global Septic arthritis Market – Overview

The global septic arthritis market is showing the moderate growth; mainly due to increase in the population suffering with diabetes, cancer, intravenous drug abuse, and immune deficiency disorders. Additionally, rising in surgery throughout the globe are considering one of the leading causes of septic arthritis. According to the WHO (2015), there are over 100 million surgical incisions every year, which are growing at a CAGR of 3.1%. Approximately 80% of these injuries use some form of closure product: sutures, staples, and tapes.

Many players are working on the segment related to Septic arthritis to introduce better treatment, such as Johnson & Johnson Inc. have three segment consumer segment, pharmaceutical segment, and medical devices segment. The pharmaceutical segment holds the maximum share of 46.55% within three segments and have focused on five therapeutic areas that include septic arthritis too. The companies are trying to introduce better technology for getting the global leader in the septic arthritis and provide a strong treatment option in the market.

Global Septic arthritis Market   -

Regional Analysis

The market of septic arthritis is much higher in the Americas region. There is a huge population suffering with diabetes and cancer. According to Centers for Disease Control and Prevention (CDC) in the year 2015, it was estimated that around 23.1 million people were diagnosed with diabetes i.e. 7.2% of the United States total population. Additionally, between 2013-2015, it was estimated that 54.4 million adults in U.S. annually had some form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia. The presence of well-developed technology, high health care spending and Increase prevalence of diabetes have boosted the growth of the market.

Europe is also considering the huge market for septic arthritis players, owing to the increasing prevalence of patient suffering with immune deficiency disorders, cancer, and diabetes. Moreover, increasing government support, and well developed technology is fuelling the market. According to the World Health Organization (WHO), in 2015 around 60 million people in the European region are currently suffering with the diabetes and the prevalence of the diabetes is increasing among all ages in the European Region. Moreover, huge health care spending has boosted the growth of the market in this region. According to the OECD, the healthcare expenditure in Germany was EUR 321 billion in 2014, which is followed by France with health care expenditure of EUR 237 billion, whereas in the United Kingdom it was EUR 223 billion.

Asia Pacific and the Middle East and Africa region are considering the big market. Whereas country like India and china of Asia Pacific region are considering fastest growing region due to the presence of huge population suffering with cancer, diabetes, and open surgery. Additionally, they are open to adopt new technology, and best treatment option from a developed country.

Report Details @ https://www.marketresearchfuture.com/reports/septic-arthritis-market-4603